Bernstein Liebhard LLP is investigating whether the Board of Directors of Genzyme Corporation (?Genzyme? or the ?Company?) (Nasdaq: GENZ) is breaching its fiduciary duty to the Company's shareholders by not agreeing to sell Genzyme to Sanofi-Aventis and/or not seeking to maximize value for the Company's shareholders.
If you are interested in discussing your rights as a Genzyme shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journal's ?Plaintiffs' Hot List? in each of the last seven years.
Bernstein Liebhard LLP |
10 East 40th Street |
New York, New York 10016 |
(877) 779-1414 |
www.bernlieb.com |
ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Bernstein Liebhard LLP
U. Seth Ottensoser, 877-779-1414
Ottensoser@bernlieb.com